Skip to content

Drug interactions

Elagolix + Lansoprazole

Severity: Minor

Elagolix and Lansoprazole: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix weakly inhibits CYP2C19 and induces CYP3A4, so lansoprazole exposure could change in either direction. Clinically important effects are not expected for most patients.

What this interaction means in plain words

Elagolix and Lansoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Elagolix belongs to Musculoskeletal; Lansoprazole belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Weak CYP2C19 inhibition and weak-to-moderate CYP3A4 induction by elagolix alter lansoprazole metabolism.

What to do

No routine adjustment is required; assess PPI response and tolerability and adjust the lansoprazole dose if needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Lansoprazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Lansoprazole?

MediHelp rates the interaction as minor. Elagolix and Lansoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Elagolix weakly inhibits CYP2C19 and induces CYP3A4, so lansoprazole exposure could change in either direction. Clinically important effects are not expected for most patients.

How serious is the interaction between Elagolix and Lansoprazole?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is required; assess PPI response and tolerability and adjust the lansoprazole dose if needed.

What other medicines interact with Lansoprazole?

MediHelp also lists interactions of Lansoprazole with, for example, Mavacamten, Rilpivirine, Acalabrutinib. The full list is on the Lansoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in